世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035659

高齢者用医薬品の世界市場(2023-2027)

TechNavio

Global Geriatric Medicines Market 2023-2027

発刊日 2023/06/02

言語英語

体裁PDF/165ページ

ライセンス/価格165ページ

0000035659

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

高齢者用医薬品市場は、2022年から2027年の間に448億5,000万米ドル成長し、予測期間中に6.81 %のCAGRで加速すると予測されています。高齢者用医薬品市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場を牽引しているのは、高齢者人口の増加、個別化医療の需要、政府やNGOによる高齢者支援の増加です。

調査範囲

  • 市場セグメント
    ➣ 流通チャネル別
      ◇ 病院薬局
      ◇ 小売薬局
      ◇ オンライン薬局
    ➣ タイプ別
      ◇ 鎮痛薬
      ◇ 糖尿病治療薬
      ◇ 抗高血圧薬
      ◇ スタチン
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

本調査では、今後数年間の高齢者用医薬品市場の成長を促進する主な理由の一つとして、治療アプローチの増加を挙げています。また、戦略的提携や買収、高齢者の健康状態を遠隔でモニタリングする積極的な役割分担は、市場の大きな需要につながるでしょう。

高齢者用医薬品市場に関するレポートは、次の分野をカバーしています。

  • 高齢者用医薬品市場の規模
  • 高齢者用医薬品市場の予測
  • 高齢者用医薬品市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、高齢者用医薬品市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

  • 調査企業
    ➣ Abbott Laboratories
    ➣ AbbVie Inc.
    ➣ AstraZeneca PLC
    ➣ Aurobindo Pharma Ltd.
    ➣ Boehringer Ingelheim International GmbH
    ➣ Bristol Myers Squibb Co.
    ➣ Cipla Ltd.
    ➣ Dr Reddys Laboratories Ltd.
    ➣ Eli Lilly and Co.
    ➣ Endo International Plc
    ➣ GlaxoSmithKline Plc
    ➣ Lupin Ltd.
    ➣ Merck and Co. Inc.
    ➣ Novartis AG, Otsuka Holdings Co. Ltd.
    ➣ Pfizer Inc.
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd., Viatris Inc.
    ➣ Sanofi

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global geriatric medicines market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global geriatric medicines market 2017 - 2021 ($ billion)
4.2 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Hospital pharmacies - Market size and forecast 2022-2027
Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
6.4 Retail pharmacies - Market size and forecast 2022-2027
Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
6.5 Online pharmacies - Market size and forecast 2022-2027
Exhibit 42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Distribution Channel
Exhibit 46: Market opportunity by Distribution Channel ($ billion)
Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 48: Chart on Type - Market share 2022-2027 (%)
Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 50: Chart on Comparison by Type
Exhibit 51: Data Table on Comparison by Type
7.3 Analgesics - Market size and forecast 2022-2027
Exhibit 52: Chart on Analgesics - Market size and forecast 2022-2027 ($ billion)
Exhibit 53: Data Table on Analgesics - Market size and forecast 2022-2027 ($ billion)
Exhibit 54: Chart on Analgesics - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Analgesics - Year-over-year growth 2022-2027 (%)
7.4 Antidiabetics - Market size and forecast 2022-2027
Exhibit 56: Chart on Antidiabetics - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Antidiabetics - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Antidiabetics - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Antidiabetics - Year-over-year growth 2022-2027 (%)
7.5 Antihypertensives - Market size and forecast 2022-2027
Exhibit 60: Chart on Antihypertensives - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Antihypertensives - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Antihypertensives - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Antihypertensives - Year-over-year growth 2022-2027 (%)
7.6 Statins - Market size and forecast 2022-2027
Exhibit 64: Chart on Statins - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Statins - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Statins - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Statins - Year-over-year growth 2022-2027 (%)
7.7 Others - Market size and forecast 2022-2027
Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Type
Exhibit 72: Market opportunity by Type ($ billion)
Exhibit 73: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 India - Market size and forecast 2022-2027
Exhibit 111: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 112: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibit 113: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on India - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ billion)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 123: Abbott Laboratories - Overview
Exhibit 124: Abbott Laboratories - Business segments
Exhibit 125: Abbott Laboratories - Key offerings
Exhibit 126: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 127: AbbVie Inc. - Overview
Exhibit 128: AbbVie Inc. - Product / Service
Exhibit 129: AbbVie Inc. - Key news
Exhibit 130: AbbVie Inc. - Key offerings
12.5 AstraZeneca PLC
Exhibit 131: AstraZeneca PLC - Overview
Exhibit 132: AstraZeneca PLC - Product / Service
Exhibit 133: AstraZeneca PLC - Key news
Exhibit 134: AstraZeneca PLC - Key offerings
12.6 Boehringer Ingelheim International GmbH
Exhibit 135: Boehringer Ingelheim International GmbH - Overview
Exhibit 136: Boehringer Ingelheim International GmbH - Business segments
Exhibit 137: Boehringer Ingelheim International GmbH - Key news
Exhibit 138: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 139: Boehringer Ingelheim International GmbH - Segment focus
12.7 Bristol Myers Squibb Co.
Exhibit 140: Bristol Myers Squibb Co. - Overview
Exhibit 141: Bristol Myers Squibb Co. - Product / Service
Exhibit 142: Bristol Myers Squibb Co. - Key news
Exhibit 143: Bristol Myers Squibb Co. - Key offerings
12.8 Dr Reddys Laboratories Ltd.
Exhibit 144: Dr Reddys Laboratories Ltd. - Overview
Exhibit 145: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 146: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 147: Dr Reddys Laboratories Ltd. - Segment focus
12.9 Eli Lilly and Co.
Exhibit 148: Eli Lilly and Co. - Overview
Exhibit 149: Eli Lilly and Co. - Product / Service
Exhibit 150: Eli Lilly and Co. - Key news
Exhibit 151: Eli Lilly and Co. - Key offerings
12.10 Endo International Plc
Exhibit 152: Endo International Plc - Overview
Exhibit 153: Endo International Plc - Business segments
Exhibit 154: Endo International Plc - Key news
Exhibit 155: Endo International Plc - Key offerings
Exhibit 156: Endo International Plc - Segment focus
12.11 GlaxoSmithKline Plc
Exhibit 157: GlaxoSmithKline Plc - Overview
Exhibit 158: GlaxoSmithKline Plc - Business segments
Exhibit 159: GlaxoSmithKline Plc - Key news
Exhibit 160: GlaxoSmithKline Plc - Key offerings
Exhibit 161: GlaxoSmithKline Plc - Segment focus
12.12 Merck and Co. Inc.
Exhibit 162: Merck and Co. Inc. - Overview
Exhibit 163: Merck and Co. Inc. - Business segments
Exhibit 164: Merck and Co. Inc. - Key news
Exhibit 165: Merck and Co. Inc. - Key offerings
Exhibit 166: Merck and Co. Inc. - Segment focus
12.13 Novartis AG
Exhibit 167: Novartis AG - Overview
Exhibit 168: Novartis AG - Business segments
Exhibit 169: Novartis AG - Key offerings
Exhibit 170: Novartis AG - Segment focus
12.14 Otsuka Holdings Co. Ltd.
Exhibit 171: Otsuka Holdings Co. Ltd. - Overview
Exhibit 172: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 173: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 174: Otsuka Holdings Co. Ltd. - Segment focus
12.15 Pfizer Inc.
Exhibit 175: Pfizer Inc. - Overview
Exhibit 176: Pfizer Inc. - Product / Service
Exhibit 177: Pfizer Inc. - Key news
Exhibit 178: Pfizer Inc. - Key offerings
12.16 Sanofi
Exhibit 179: Sanofi - Overview
Exhibit 180: Sanofi - Business segments
Exhibit 181: Sanofi - Key news
Exhibit 182: Sanofi - Key offerings
Exhibit 183: Sanofi - Segment focus
12.17 Teva Pharmaceutical Industries Ltd.
Exhibit 184: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 185: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 186: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 187: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 188: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 189: Inclusions checklist
Exhibit 190: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 191: Currency conversion rates for US$
13.4 Research methodology
Exhibit 192: Research methodology
Exhibit 193: Validation techniques employed for market sizing
Exhibit 194: Information sources
13.5 List of abbreviations
Exhibit 195: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global geriatric medicines market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ billion)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits48: Chart on Type - Market share 2022-2027 (%)
Exhibits49: Data Table on Type - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Analgesics - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Analgesics - Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Analgesics - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Analgesics - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Antidiabetics - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Antidiabetics - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Antidiabetics - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Antidiabetics - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Antihypertensives - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Antihypertensives - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Antihypertensives - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Antihypertensives - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Statins - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Statins - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Statins - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Statins - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits72: Market opportunity by Type ($ billion)
Exhibits73: Data Table on Market opportunity by Type ($ billion)
Exhibits74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits77: Chart on Geographic comparison
Exhibits78: Data Table on Geographic comparison
Exhibits79: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on India - Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on India - Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits115: Market opportunity By Geographical Landscape ($ billion)
Exhibits116: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits117: Impact of drivers and challenges in 2022 and 2027
Exhibits118: Overview on Criticality of inputs and Factors of differentiation
Exhibits119: Overview on factors of disruption
Exhibits120: Impact of key risks on business
Exhibits121: Vendors covered
Exhibits122: Matrix on vendor position and classification
Exhibits123: Abbott Laboratories - Overview
Exhibits124: Abbott Laboratories - Business segments
Exhibits125: Abbott Laboratories - Key offerings
Exhibits126: Abbott Laboratories - Segment focus
Exhibits127: AbbVie Inc. - Overview
Exhibits128: AbbVie Inc. - Product / Service
Exhibits129: AbbVie Inc. - Key news
Exhibits130: AbbVie Inc. - Key offerings
Exhibits131: AstraZeneca PLC - Overview
Exhibits132: AstraZeneca PLC - Product / Service
Exhibits133: AstraZeneca PLC - Key news
Exhibits134: AstraZeneca PLC - Key offerings
Exhibits135: Boehringer Ingelheim International GmbH - Overview
Exhibits136: Boehringer Ingelheim International GmbH - Business segments
Exhibits137: Boehringer Ingelheim International GmbH - Key news
Exhibits138: Boehringer Ingelheim International GmbH - Key offerings
Exhibits139: Boehringer Ingelheim International GmbH - Segment focus
Exhibits140: Bristol Myers Squibb Co. - Overview
Exhibits141: Bristol Myers Squibb Co. - Product / Service
Exhibits142: Bristol Myers Squibb Co. - Key news
Exhibits143: Bristol Myers Squibb Co. - Key offerings
Exhibits144: Dr Reddys Laboratories Ltd. - Overview
Exhibits145: Dr Reddys Laboratories Ltd. - Business segments
Exhibits146: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits147: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits148: Eli Lilly and Co. - Overview
Exhibits149: Eli Lilly and Co. - Product / Service
Exhibits150: Eli Lilly and Co. - Key news
Exhibits151: Eli Lilly and Co. - Key offerings
Exhibits152: Endo International Plc - Overview
Exhibits153: Endo International Plc - Business segments
Exhibits154: Endo International Plc - Key news
Exhibits155: Endo International Plc - Key offerings
Exhibits156: Endo International Plc - Segment focus
Exhibits157: GlaxoSmithKline Plc - Overview
Exhibits158: GlaxoSmithKline Plc - Business segments
Exhibits159: GlaxoSmithKline Plc - Key news
Exhibits160: GlaxoSmithKline Plc - Key offerings
Exhibits161: GlaxoSmithKline Plc - Segment focus
Exhibits162: Merck and Co. Inc. - Overview
Exhibits163: Merck and Co. Inc. - Business segments
Exhibits164: Merck and Co. Inc. - Key news
Exhibits165: Merck and Co. Inc. - Key offerings
Exhibits166: Merck and Co. Inc. - Segment focus
Exhibits167: Novartis AG - Overview
Exhibits168: Novartis AG - Business segments
Exhibits169: Novartis AG - Key offerings
Exhibits170: Novartis AG - Segment focus
Exhibits171: Otsuka Holdings Co. Ltd. - Overview
Exhibits172: Otsuka Holdings Co. Ltd. - Business segments
Exhibits173: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits174: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits175: Pfizer Inc. - Overview
Exhibits176: Pfizer Inc. - Product / Service
Exhibits177: Pfizer Inc. - Key news
Exhibits178: Pfizer Inc. - Key offerings
Exhibits179: Sanofi - Overview
Exhibits180: Sanofi - Business segments
Exhibits181: Sanofi - Key news
Exhibits182: Sanofi - Key offerings
Exhibits183: Sanofi - Segment focus
Exhibits184: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits185: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits186: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits187: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits188: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits189: Inclusions checklist
Exhibits190: Exclusions checklist
Exhibits191: Currency conversion rates for US$
Exhibits192: Research methodology
Exhibits193: Validation techniques employed for market sizing
Exhibits194: Information sources
Exhibits195: List of abbreviations

この商品のレポートナンバー

0000035659

最近見たレポート

プロゲストロンの世界市場規模調査・予測:タイプ別、デリバリー形態別、用途別、地域別の分析(2023年〜2030年)

Global Progesterone Market Size study & Forecast, by Type (Natural Progesterone, Synthetic Progesterone), By Mode of Delivery (Injectable, Suspended Form, Oral), By Application (Regulation of the Menstrual Cycle, Dysfunctional Uterine Bleeding, Endometrial Cancer, Contraception, Hyperplastic Precursor Lesions) and Regional Analysis, 2023-2030

2023/07/01

4,950 USD

炎症性腸疾患の世界市場(2023-2027)

Global Inflammatory Bowel Disease Market 2023-2027

2023/06/12

2,500 USD

TOP